New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 11, 2013
16:08 EDTCRMDCorMedix files to sell 3.78M shares of common stock for holders
News For CRMD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 25, 2014
08:10 EDTCRMDCorMedix files IND application for Neutrolin in the U.S.
CorMedix submitted an Investigational New Drug application for Neutrolin to the FDA on September 24. The IND includes a pivotal Phase 3 protocol for Neutrolin in hemodialysis patients with a central venous catheter. The Phase 3 clinical trial is designed as a multi-center, randomized, controlled study conducted in the U.S. and Europe.
September 22, 2014
08:02 EDTCRMDCorMedix announces label expansion for Neutrolin for European Union
CorMedix announced that TUV-SUD and The Medicinal Evaluation Board of the Netherlands has granted its request for a label expansion for Neutrolin, its catheter lock solution. Neutrolin was initially approved in July 2013 for use in the prevention of catheter-related bloodstream infections and maintenance of catheter patency in hemodialysis patients using a tunneled, cuffed central venous catheter for vascular access. The label expansion includes approval for additional indications for use in oncology patients receiving chemotherapy, IV hydration and IV medications via central venous catheters. The expansion also includes patients receiving medication and IV fluids via central venous catheters in intensive or critical care units. An indication for use in total parenteral nutrition was also approved.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use